Screener
Aurinia Pharmaceuticals AUPH Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Aurinia Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Aurinia Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:16 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001600620-26-000062
FAQ
- What is Aurinia Pharmaceuticals's asset turnover?
- Aurinia Pharmaceuticals (AUPH) reported asset turnover of 0.5× in Q2 2026.
- How has Aurinia Pharmaceuticals's asset turnover changed year-over-year?
- Aurinia Pharmaceuticals's asset turnover decreased by 5.1% year-over-year, from 0.5× to 0.5×.
- What is the long-term trend for Aurinia Pharmaceuticals's asset turnover?
- Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's asset turnover has grown at a 27.9% compound annual growth rate (CAGR), from 0.1× to 0.4×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Aurinia Pharmaceuticals's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude